Methylated-CpG Island Recovery Assay
Alterations in DNA methylation patterns are implicated in playing a major role in the development of cancer, thus highlighting the need to continually develop new technologies to analyze epigenetic marks. Methylated-CpG Island Recovery Assay (MIRA), based on the high affinity of the MBD2b/MDB3L1 complex for double-stranded methylated DNA, allows for the recovery of methylated DNA without the use of bisulfite conversion or antibody recognition. MIRA is capable of detecting low-density methylation of a single methylated CpG nucleotide. This technique can be used in conjunction with microarrays or next-generation sequencing to analyze recovered methylated DNA on a genome-wide scale.
- AAV-Mediated Gene Transfer to Skeletal Muscle
- Optimizing Particle-Mediated Epidermal Delivery of an Influenza DNA Vaccine in Ferrets
- Immuno-Slot Blot Assay for Detection of UVR-Mediated DNA Damage
- Site-Directed Mutagenesis by the Cassette Method
- Introduction to miRNA Profiling Technologies and Cross-Platform Comparison
- Statistical Issues in Gene Association Studies
- Statistical Methods Employed in Evaluation of Single-Locus Probe Results in Criminal Identity Cases
- In Silico Design of Functional DNA Constructs
- Analytical Methods for Immunogenetic Population Data
- Immunocytochemical Fluorescent In Situ Visualization of Proteins In Arabidopsis